baicalin has been researched along with 3,7-dihydroxyflavone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Claasen, B; Giralt, E; Kichik, N; Prades, R; Tarragó, T; Teixidó, M | 1 |
| Amić, D; Lucić, B | 1 |
2 other study(ies) available for baicalin and 3,7-dihydroxyflavone
| Article | Year |
|---|---|
Baicalin, a prodrug able to reach the CNS, is a prolyl oligopeptidase inhibitor.
Topics: Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavanones; Flavonoids; Prolyl Oligopeptidases; Serine Endopeptidases; Structure-Activity Relationship | 2008 |
Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids.
Topics: Flavonoids; Free Radical Scavengers; Models, Biological; Quantitative Structure-Activity Relationship; Quantum Theory; Software; Thermodynamics | 2010 |